Literature DB >> 11945076

Design of HIV vectors for efficient gene delivery into human hematopoietic cells.

Priscilla Y Yam1, Shulian Li, Jerry Wu, Jun Hu, John A Zaia, Jiing-Kuan Yee.   

Abstract

Vectors derived from human immunodeficiency virus (HIV) hold promise for efficient gene delivery into human hematopoietic cells. In this study, HIV vectors containing different combinations of cis-acting elements, including the HIV central flap sequence, and the woodchuck posttranscriptional regulatory element (WPRE) in combination with two different promoters, were used to transduce primary human lymphocytes and cord blood CD34+ progenitor cells. The effect of these elements on the transduction efficiency and transgene expression was systematically evaluated. The results demonstrate that with the combination of flap, WPRE sequences, and the promoter derived from spleen focus-forming virus (SFFV), a foreign gene can be efficiently delivered into primary human T lymphocytes and cord blood CD34+ cells. The study establishes the parameters for proper vector design to efficiently deliver foreign genes into human hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945076     DOI: 10.1006/mthe.2002.0558

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  63 in total

1.  Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.

Authors:  Dibyakanti Mandal; Zehua Feng; C Martin Stoltzfus
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  The use of cell-delivered gene therapy for the treatment of HIV/AIDS.

Authors:  Geoff P Symonds; Helen A Johnstone; Michelle L Millington; Maureen P Boyd; Bryan P Burke; Louis R Breton
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.

Authors:  Sylvanne M Daniels; Lucile Sinck; Natalie J Ward; Carlos E Melendez-Peña; Robert J Scarborough; Ibrahim Azar; Elodie Rance; Aïcha Daher; Ka-Ming Pang; John J Rossi; Anne Gatignol
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.

Authors:  Elena Herrera-Carrillo; Ying Poi Liu; Ben Berkhout
Journal:  Mol Ther       Date:  2013-12-12       Impact factor: 11.454

5.  Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.

Authors:  Touraj Farazmandfar; Mohammad Reza Haghshenas; Majid Shahbazi
Journal:  Hum Gene Ther       Date:  2015-08-06       Impact factor: 5.695

6.  Site-specific gene insertion mediated by a Cre-loxP-carrying lentiviral vector.

Authors:  Gilles Michel; Yin Yu; Tammy Chang; Jiing-Kuan Yee
Journal:  Mol Ther       Date:  2010-07-13       Impact factor: 11.454

7.  Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression.

Authors:  Randolph H Hastings; Philippe R Montgrain; Rick A Quintana; Boris Chobrutskiy; Ashkhan Davani; Atsushi Miyanohara; Sepi Mahooti
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-25       Impact factor: 4.553

8.  Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity.

Authors:  Patrick Ho; Christopher Ede; Yvonne Y Chen
Journal:  ACS Synth Biol       Date:  2017-05-22       Impact factor: 5.110

9.  HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

Authors:  Christoph C Carter; Adewunmi Onafuwa-Nuga; Lucy A McNamara; James Riddell; Dale Bixby; Michael R Savona; Kathleen L Collins
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

10.  Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activation.

Authors:  Rachael Kenworthy; Diana Lambert; Feng Yang; Nan Wang; Zihong Chen; Haizhen Zhu; Fanxiu Zhu; Chen Liu; Kui Li; Hengli Tang
Journal:  Nucleic Acids Res       Date:  2009-09-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.